Biological variation of proprotein convertase subtilisin/kexin type 9 (PCSK9) in human serum.

• Within-subject biological variation of PCSK9 in human serum was 23.2%, between-subject biological variation was 10.9%. • Index of individuality was 2.13, thus enabling the use of reference intervals. • Reference change value was 66.3%. • The estimation of homeostatic point can be based on at least...

Full description

Saved in:
Bibliographic Details
Published in:Clinica Chimica Acta Vol. 521; pp. 59 - 64
Main Authors:
Format: Article
Published: Elsevier B.V., Oct2021
Subjects:
Online Access:Go to the source
Tags: Add Tag
Be the first to tag this record!
fields Array ( [recordID] => 1 )
Array ( )
http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=151912955&site=ehost-live
Array ( [@attributes] => Array ( [shortDbName] => a9h [uiTerm] => 151912955 [longDbName] => Academic Search Complete [uiTag] => AN ) [controlInfo] => Array ( [bkinfo] => Array ( ) [jinfo] => Array ( [jid] => Array ( [0] => 00098981 [1] => 3H8 ) [jtl] => Clinica Chimica Acta [issn] => 00098981 [maglogo] => N ) [pubinfo] => Array ( [dt] => Oct2021 [vid] => 521 [pub] => Elsevier B.V. ) [artinfo] => Array ( [ui] => Array ( [0] => 151912955 [1] => 10.1016/j.cca.2021.06.023 ) [ppf] => 59 [ppct] => 5 [formats] => Array ( ) [tig] => Array ( [atl] => Biological variation of proprotein convertase subtilisin/kexin type 9 (PCSK9) in human serum. ) [aug] => Array ( [au] => Array ( [0] => Jabor, Antonín [1] => Vacková, Tereza [2] => Kubíček, Zdenek [3] => Komrsková, Jitka [4] => Protuš, Marek [5] => Franeková, Janka ) [affil] => Array ( [0] => Institute for Clinical and Experimental Medicine, Department of Laboratory Methods, Vídeňská 1958/9, 140 21 Praha 4, Czech Republic [1] => Third Faculty of Medicine, Charles University, Ruská 87, 100 00 Praha 10, Czech Republic [2] => Department of Anesthesiology, Resuscitation, and Intensive Care, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Praha 4, Czech Republic [3] => First Faculty of Medicine, Charles University, Kateřinská 1660/32, 121 08 Praha 2, Czech Republic ) ) [su] => Array ( [0] => GERMANY [1] => GREAT Britain [2] => BIOLOGICAL variation [3] => HUMAN variation (Biology) [4] => SUBTILISINS [5] => REFERENCE values [6] => FIX-point estimation [7] => LOW density lipoprotein receptors ) [sug] => Array ( [subj] => Array ( [0] => BIOLOGICAL variation [1] => HUMAN variation (Biology) [2] => SUBTILISINS [3] => REFERENCE values [4] => FIX-point estimation [5] => LOW density lipoprotein receptors [6] => GERMANY [7] => GREAT Britain ) ) [keyword] => Array ( [0] => Biological variation [1] => Index of individuality [2] => Proprotein convertase subtilisin/kexin type 9 (PCSK9) [3] => Reference change value ) [ab] => • Within-subject biological variation of PCSK9 in human serum was 23.2%, between-subject biological variation was 10.9%. • Index of individuality was 2.13, thus enabling the use of reference intervals. • Reference change value was 66.3%. • The estimation of homeostatic point can be based on at least 3 blood samples to assess its value within ±25%. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in the regulation of LDL receptors. Inhibition of PCSK9 increase uptake of LDL-particles and pathogen-associated molecular patterns (PAMPs). The aim of our study was to evaluate biological variation of serum PCSK9. Within-subject (CV I) and between-subject (CV G) biological variations were assessed in 14 healthy volunteers in a 6-week protocol (7 samples, equidistant time intervals). Serum concentration of PCSK9 was measured by a Quantikine ELISA assay (R&D systems, Bio-Techne Ltd., UK) on a DS2 ELISA reader (Dynex Technologies GmbH, Germany). Precision (CV A) was assessed by duplicate measurements. Two methods with different levels of robustness were used for the estimation of CV I , SD-ANOVA and CV-ANOVA method. We calculated the index of individuality and reference change values. The experiment was fully compliant with EFLM database checklist. The within-subject values of PCSK9 in healthy persons, as calculated by two statistical methods, were 23.2% (SD-ANOVA with CV A of 5.6%) and 26.6% (CV-ANOVA with CV A of 4.8%). The CV G was 10.9% (SD-ANOVA), index of individuality and RCV were 2.13 and 66.3%, respectively. The high index of individuality indicates that common reference intervals can be used to interpret serum PSCK9 values. [pubtype] => Academic Journal [doctype] => Article [src] => R ) [language] => English [refInfo] => Array ( ) [copyright] => Array ( [@attributes] => Array ( [flag] => Y ) [dt] => Array ( [@attributes] => Array ( [year] => 2021 ) ) ) [holdings] => Array ( [@attributes] => Array ( [islocal] => N ) ) ) )